The Committee for Proprietary Medicinal Products, having regard to its Opinion of 8 June 1995 and the grounds for appeal submitted on 11 August 1995, is of the Opinion that marketing authorisations for all medicinal products referred to in the Annexe to this final opinion should be withdrawn.